United States· US:84712-042_27f4973e-0bbb-696c-e063-6394a90aa3bf
BARUBT MATTE UNIVERSAL TINTED MOISTURIZER
A medicinal product containing niacinamide; polygonum aviculare whole, registered in United States by Guangdong Youbaijia Cosmetic Industry Co., Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NIACINAMIDE; POLYGONUM AVICULARE WHOLE
- Manufacturer
- Guangdong Youbaijia Cosmetic Industry Co., Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 2
- ndc1184712-042-01
- ndc11847120420150 mL in 1 BOTTLE (84712-042-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e22b030-3b11-4cf1-b214-adaf57a23372 GET /v1/drugs/8e22b030-3b11-4cf1-b214-adaf57a23372?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS; TOPICAL",
"source": "ndc",
"strength": "2.5; .25",
"substance": "NIACINAMIDE; POLYGONUM AVICULARE WHOLE",
"productndc": "84712-042",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/50mL; g/50mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about niacinamide; polygonum aviculare whole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.